Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale

AUTOR(ES)

Potter, Jean

FONTE

The Royal Society of Medicine

RESUMO

The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is a simple bedside test in two parts—a patient-completed questionnaire and a brief clinical assessment. Its diagnostic capabilities have never been tested in patients with cancer pain. To determine these we conducted a prospective study in outpatients with head and neck cancer. All patients with pain completed the LANSS and underwent a medical assessment with a palliative care physician, whose findings were then reviewed by a pain specialist blinded to the LANSS scores. We assessed acceptability and understanding of the LANSS by patients and calculated the sensitivity and specificity of total LANSS scores and subscores derived from the patient-completed section.

Documentos Relacionados

• Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy
• Gene therapy in head and neck cancer: a review
• Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan
• Pain assessment in critical patients using the Behavioral Pain Scale
• Questionnaire assessment based on signs, symptoms and history in the prevention of colorectal cancer